查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829652

2025年全球冠状动脉支架市场报告

Coronary Stents Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，冠状动脉支架市场规模强劲成长，从2024年的110.6亿美元增加至2025年的119亿美元，复合年增长率为7.6%。预测期内的增长可归因于人们对微创手术的日益偏好、新兴市场医疗服务可及性的不断扩大、医疗成本的不断上涨、经皮冠状动脉介入治疗的增多以及循环系统数量的不断增长。

预计未来几年冠状动脉支架市场将强劲成长，到2029年将达到164亿美元，年复合成长率（CAGR）为8.3%。预测期内的成长动力包括心血管疾病盛行率的上升、人口老化、心血管健康意识的增强、政府支持计画和资金投入以及文明病盛行率的上升。预测期内的主要趋势包括支架技术创新、成像技术创新、策略联盟与伙伴关係关係、支架材料创新以及技术与数位健康的融合。

冠状动脉支架：支架是一种小型可扩张的管状结构，用于疏通冠状动脉狭窄或阻塞部位，从而为心肌供血。支架通常由金属网构成，在经皮冠状动脉介入治疗 (PCI) 或血管成形术中置入。支架经由球囊导管送入，并在阻塞部位扩张，恢復正常的血流。

冠状动脉支架的主要类型包括双疗支架、放射性支架、血栓切除支架、涂层支架、生物可吸收支架、生物可降解支架、混合支架、药物释放型支架和裸金属支架。双疗支架整合了药物释放型和生物可吸收技术，既提供药物释放，也提供支架结构的逐渐吸收。支架采用多种技术製造，包括雷射切割、3D 列印、微加工、奈米技术和电解。用于製造支架的材料包括钴铬、不銹钢、铂铬和镍钛。支架有自膨胀和球囊扩张型，用于医院、门诊手术中心、专科诊所和其他医疗机构。

2025年春季，美国关税突然上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战进一步加剧了形势，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供冠状动脉支架市场统计数据，包括全球冠状动脉支架行业规模、各地区市场份额、竞争对手的冠状动脉支架市场份额、详细的冠状动脉支架细分市场、市场趋势和商业机会，以及您在冠状动脉支架行业取得成功所需的数据。本冠状动脉支架市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的全方位观点。

未来五年的预测成长率为8.3%，较我们先前对该市场的预测略有下降0.1%。这一下降主要源于美国与其他国家之间关税的影响，这可能会直接影响美国，因为来自爱尔兰和新加坡等主要地区的药物释放型洗脱聚合物涂层和钴铬支架平台的供应链将中断。

心血管疾病 (CVD) 盛行率的不断上升预计将推动冠状动脉支架市场的扩张。 CVD 包括各种心臟和血管疾病，例如冠状动脉疾病、心臟衰竭、中风和高血压。心血管疾病的增加归因于人口老化以及肥胖、糖尿病、久坐不动的生活方式、不良饮食和压力等风险因素的增加。冠状动脉支架在 CVD 治疗中至关重要，因为它可以打开狭窄或阻塞的冠状动脉，改善心臟血流，降低心臟病发作的风险。例如，美国心臟学会于2022年8月发布的报告预测，2025年至2060年间，美国心血管危险因子将显着增加。报告预测，糖尿病患者将增加39.3%，达到5,500万人；血脂异常症将增加27.6%，达到1.26亿人；高血压患者将增加25.1%，达1.62亿人；肥胖患者将增加18.3%，达1.26亿人。其中，最显着的成长是中风（增加33.8%，达到1500万人）和心臟衰竭（增加33.4%，达到1300万人），缺血性心臟疾病和心臟病发作也呈现显着增长。心血管疾病盛行率的上升推动了对冠状动脉支架的需求。

冠状动脉支架市场的公司正专注于开发药物释放型支架等先进产品，以最大限度地减少与传统裸金属支架相比再次手术的需求。药物释放型支架是一种特殊涂层的装置，可缓慢释放药物，防止动脉再次变窄。例如，2024年5月，美国医疗保健公司雅培在印度推出了XIENCE Sierra依维莫司洗脱冠状动脉支架系统。此支架采用增强型设计、全新输送系统和独特的尺寸选择，适用于复杂病例。与其他XIENCE支架一样，该支架也涂有特殊涂层，可降低动脉再次阻塞的风险，并拥有强大的安全记录，该记录得到了120多项临床试验的支持，涉及超过12万名患者。

2022年10月，总部位于美国的心血管和血管内器械开发商Cordis以未披露的金额收购了MedAlliance。此次收购将使Cordis能够在2027年前将其SELUTION SLR（Limus缓释）药物释放型球囊带给全球200万名患者。 Cordis也将在其现有市场共同促销MedAlliance的SELUTION SLR药物释放型球囊。 MedAlliance是一家总部位于瑞士的冠状动脉支架製造商。

冠状动脉支架市场由提供产品培训和教育、技术和临床支援、研发以及客製化解决方案等服务的营业单位获得的收益所构成。市场价值还包括服务供应商销售的或包含在其服务产品中的相关商品的价值。冠状动脉支架市场还包括覆膜支架、球囊导管、导管导引线、栓塞保护装置和影像系统的销售。此市场价值为“出厂价”，即商品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球冠状动脉支架：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球冠状动脉支架市场：成长率分析
  • 全球冠状动脉支架市场表现：规模与成长，2019-2024
  • 全球冠状动脉支架市场预测：规模与成长，2024-2029年，2034年
  • 全球冠状动脉支架：总目标市场（TAM）

第六章 市场细分

  • 全球冠状动脉支架市场：依产品类型、效能和预测，2019-2024 年、2024-2029 年、2034 年
  • 双疗法支架
  • 放射性支架
  • 血栓切除支架
  • 覆膜支架
  • 生物可吸收支架
  • 可生物降解支架
  • 混合支架
  • 药物释放型支架
  • 裸金属支架
  • 全球冠状动脉支架市场：按技术、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 雷射切割
  • 3D列印支架
  • 微加工
  • 基于奈米技术的支架
  • 电解抛光
  • 其他技术
  • 全球冠状动脉支架市场：按材料、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 钴铬合金
  • 不銹钢
  • 铂铬
  • 镍钛合金
  • 聚合物
  • 全球冠状动脉支架市场：按部署、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 自动扩张型支架
  • 球囊扩张型支架
  • 全球冠状动脉支架市场最终用途、绩效及预测（2019-2024年、2024-2029年、2034年）
  • 医院及门诊手术中心
  • 专科诊所
  • 其他用途
  • 全球冠状动脉支架市场：双疗法支架细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • Sirolimus洗脱双疗支架
  • 紫杉醇洗脱双疗支架
  • Everolimus洗脱双疗支架
  • 全球冠状动脉支架市场：以放射性支架细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • β射线支架
  • 伽玛射线支架
  • 其他放射支架
  • 全球冠状动脉支架市场：血栓切除支架细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 手动血栓切除支架
  • 机械血栓切除支架
  • 动态血栓切除支架
  • 全球冠状动脉支架市场：覆盖支架细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • PTFE涂层支架
  • ePTFE覆膜支架
  • 聚氨酯涂层支架
  • 其他覆膜支架
  • 全球冠状动脉支架市场：依生物可吸收支架细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 聚合物基生物可吸收支架
  • 金属基生物可吸收支架
  • 陶瓷基生物可吸收支架
  • 全球冠状动脉支架市场：按可生物降解支架类型细分、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 聚合物可生物降解支架
  • 镁基可生物降解支架
  • 其他可生物降解支架
  • 全球冠状动脉支架市场：按混合支架类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 混合药物释放型支架
  • 混合可生物降解支架或金属支架
  • 其他混合支架
  • 全球冠状动脉支架市场：药物释放型支架细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • Sirolimus洗脱支架
  • 紫杉醇洗脱支架
  • Everolimus洗脱支架
  • 佐他莫司洗脱支架
  • 其他药物释放型支架
  • 全球冠状动脉支架市场：裸金属支架细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 不銹钢裸金属支架
  • 钴铬裸金属支架
  • 其他裸金属支架

第七章 区域和国家分析

  • 全球冠状动脉支架市场：区域分析、预测与趋势（2019-2024 年、2024-2029 年、2034 年）
  • 全球冠状动脉支架市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 冠状动脉支架市场：竞争格局
  • 冠状动脉支架市场：公司简介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • Biosensors International Group Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Terumo Corporation
  • WL Gore & Associates Inc.
  • Cook Medical Inc.
  • BIOTRONIK SE & Co. KG
  • Lepu Medical Technology（Beijing）Co. Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • OrbusNeich
  • Asahi Intecc Co. Ltd.
  • Sahajanand Medical Technologies Limited
  • Translumina GmbH
  • Stentys SA
  • Sorin Group
  • InspireMD Inc.
  • CR Bard Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年冠状动脉支架市场：提供新机会的国家
  • 2029年冠状动脉支架市场：细分市场带来新机会
  • 2029年冠状动脉支架市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r29898u

Coronary stents are small, expandable tubes used to open narrowed or blocked coronary arteries, which supply blood to the heart muscle. Typically constructed from metal mesh, these devices are inserted during a procedure known as percutaneous coronary intervention (PCI) or angioplasty. The stent is delivered via a balloon catheter and expanded at the blockage site to restore proper blood flow.

The main types of coronary stents include dual therapy stents, radioactive stents, thrombectomy stents, covered stents, bioresorbable stents, biodegradable stents, hybrid stents, drug-eluting stents, and bare metal stents. Dual therapy stents integrate drug-eluting and bioresorbable technologies to offer both medication release and gradual absorption of the stent structure. Various technologies used in their manufacture include laser cutting, 3D printing, microfabrication, nanotechnology, and electropolishing. Materials used in stent production can include cobalt-chromium, stainless steel, platinum-chromium, and nickel-titanium. Stents can be self-expandable or balloon-expandable and are utilized by hospitals, ambulatory surgical centers, specialty clinics, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The coronary stents market research report is one of a series of new reports from The Business Research Company that provides coronary stents market statistics, including coronary stents industry global market size, regional shares, competitors with a coronary stents market share, detailed coronary stents market segments, market trends and opportunities, and any further data you may need to thrive in the coronary stents industry. This coronary stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The coronary stents market size has grown strongly in recent years. It will grow from $11.06 billion in 2024 to $11.9 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to growing preference for minimally invasive procedures, expansion of healthcare access in emerging markets, rising healthcare expenditure, increase in percutaneous coronary interventions, growing number of cardiologists.

The coronary stents market size is expected to see strong growth in the next few years. It will grow to $16.4 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing incidence of cardiovascular diseases, aging population, rising awareness about cardiovascular health, supportive government programs and funding, growing incidence of lifestyle diseases. Major trends in the forecast period include innovations in stent technology, innovations in imaging technologies, strategic collaborations and partnerships, innovations in stent materials, technological integration with digital health.

The forecast of 8.3% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for drug-eluting polymer coatings and cobalt-chromium stent platforms, sourced from key regions such as Ireland and Singapore, which could lead to shortages in life-saving cardiac devices and increased angioplasty costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of cardiovascular diseases (CVDs) is anticipated to drive the expansion of the coronary stent market. CVDs encompass a range of heart and blood vessel disorders, including coronary artery disease, heart failure, stroke, and hypertension. The rise in cardiovascular diseases is attributed to factors such as an aging population, increased rates of risk factors such as obesity, diabetes, sedentary lifestyles, poor diet, and stress. Coronary stents are crucial in treating CVDs as they help open narrowed or blocked coronary arteries, improving blood flow to the heart and reducing the risk of heart attacks. For example, a report from the American College of Cardiology in August 2022 projected significant increases in cardiovascular risk factors in the U.S. from 2025 to 2060. It predicted a 39.3% increase in diabetes cases to 55 million, a 27.6% rise in dyslipidemia to 126 million, a 25.1% increase in hypertension to 162 million, and an 18.3% rise in obesity to 126 million. The most notable increases are expected in stroke (33.8% rise to 15 million) and heart failure (33.4% rise to 13 million), with ischemic heart disease and heart attacks also showing substantial growth. This rising prevalence of CVDs is driving the demand for coronary stents.

Companies in the coronary stent market are focusing on developing advanced products such as drug-eluting stents to minimize the need for repeat procedures compared to traditional bare-metal stents. Drug-eluting stents are specialized devices coated with medication that gradually releases drugs to prevent the re-narrowing of arteries. For instance, in May 2024, Abbott, a US-based healthcare company, introduced the XIENCE Sierra Everolimus Eluting Coronary Stent System in India. This stent features an enhanced design, a new delivery system, and unique size options tailored for complex cases. It maintains a specialized coating to reduce the risk of artery re-blockage, consistent with other XIENCE stents, and boasts a strong safety record supported by over 120 clinical trials involving more than 120,000 patients.

In October 2022, Cordis, a US-based developer of cardiovascular and endovascular devices, acquired MedAlliance for an undisclosed amount. This acquisition will enable Cordis to reach two million patients globally by 2027 with the SELUTION SLR (Sustained Limus Release) drug-eluting balloon. Cordis will also co-promote MedAlliance's SELUTION SLR drug-eluting balloon in existing markets. MedAlliance is a Switzerland-based manufacturer of coronary stents.

Major companies operating in the coronary stents market are Abbott Laboratories, Medtronic Plc, Biosensors International Group Ltd., Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc., Cook Medical Inc., BIOTRONIK SE & Co. KG, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd, MicroPort Scientific Corporation, OrbusNeich, Asahi Intecc Co. Ltd., Sahajanand Medical Technologies Limited, Translumina GmbH, Stentys S.A., Sorin Group, InspireMD Inc., C. R. Bard Inc., AMG International GmbH, Svelte Medical Systems Inc., Zorion Medical Inc., Spectranetics Corporation

North America was the largest region in the coronary stents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the coronary stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The coronary stent market consists of revenues earned by entities by providing services such as product training and education, technical support, clinical support, research and development, customized solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The coronary stent market also includes sales of covered stents, balloon catheters, guidewires, embolic protection devices and imaging systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Coronary Stents Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on coronary stents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for coronary stents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The coronary stents market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Dual Therapy Stents; Radioactive Stents; Thrombectomy Stents; Covered Stents; Bioresorbable Stents; Biodegradable Stents; Hybrid Stents; Drug-Eluting Stents; Bare Metal Stents
  • 2) By Technology: Laser Cutting; 3D-Printed Stents; Microfabrication; Nanotechnology-Based Stents; Electropolishing; Others Technologies
  • 3) By Raw Material: Cobalt-Chromium; Stainless Steel; Platinum-Chromium; Nickel-Titanium; Polymer
  • 4) By Deployment: Self-Expandable Stents; Balloon-Expandable Stents
  • 5) By End Uses: Hospitals And Ambulatory Surgical Centers; Specialty Clinics; Other End Uses
  • Subsegments:
  • 1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents; Paclitaxel-Eluting Dual Therapy Stents; Everolimus-Eluting Dual Therapy Stents
  • 2) By Radioactive Stents: Beta Radiation Stents; Gamma Radiation Stents; Other Radiation Stents
  • 3) By Thrombectomy Stents: Manual Thrombectomy Stents; Mechanical Thrombectomy Stents; Hydrodynamic Thrombectomy Stents
  • 4) By Covered Stents: PTFE-Covered Stents; ePTFE-Covered Stents; Polyurethane-Covered Stents; Other Covered Stents
  • 5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents; Metal-Based Bioresorbable Stents; Ceramic-Based Bioresorbable Stents
  • 6) By Biodegradable Stents: Polymeric Biodegradable Stents; Magnesium-Based Biodegradable Stents; Other Biodegradable Stents
  • 7) By Hybrid Stents: Hybrid Drug-Eluting Stents; Hybrid Biodegradable Or Metal Stents; Other Hybrid Stents
  • 8) By Drug-Eluting Stents: Sirolimus-Eluting Stents; Paclitaxel-Eluting Stents; Everolimus-Eluting Stents; Zotarolimus-Eluting Stents; Other Drug-Eluting Stents
  • 9) By Bare Metal Stents: Stainless Steel Bare Metal Stents; Cobalt Chromium Bare Metal Stents; Other Bare Metal Stents
  • Companies Mentioned: Abbott Laboratories; Medtronic Plc; Biosensors International Group Ltd.; Boston Scientific Corporation; B. Braun Melsungen AG; Terumo Corporation; W. L. Gore & Associates Inc.; Cook Medical Inc.; BIOTRONIK SE & Co. KG; Lepu Medical Technology (Beijing) Co. Ltd.; Meril Life Sciences Pvt. Ltd; MicroPort Scientific Corporation; OrbusNeich; Asahi Intecc Co. Ltd.; Sahajanand Medical Technologies Limited; Translumina GmbH; Stentys S.A.; Sorin Group; InspireMD Inc.; C. R. Bard Inc.; AMG International GmbH; Svelte Medical Systems Inc.; Zorion Medical Inc.; Spectranetics Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Coronary Stents Market Characteristics

3. Coronary Stents Market Trends And Strategies

4. Coronary Stents Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Coronary Stents Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Coronary Stents PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Coronary Stents Market Growth Rate Analysis
  • 5.4. Global Coronary Stents Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Coronary Stents Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Coronary Stents Total Addressable Market (TAM)

6. Coronary Stents Market Segmentation

  • 6.1. Global Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dual Therapy Stents
  • Radioactive Stents
  • Thrombectomy Stents
  • Covered Stents
  • Bioresorbable Stents
  • Biodegradable Stents
  • Hybrid Stents
  • Drug-Eluting Stents
  • Bare Metal Stents
  • 6.2. Global Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laser Cutting
  • 3D-Printed Stents
  • Microfabrication
  • Nanotechnology-Based Stents
  • Electropolishing
  • Others Technologies
  • 6.3. Global Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cobalt-Chromium
  • Stainless Steel
  • Platinum-Chromium
  • Nickel-Titanium
  • Polymer
  • 6.4. Global Coronary Stents Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Self-Expandable Stents
  • Balloon-Expandable Stents
  • 6.5. Global Coronary Stents Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Ambulatory Surgical Centers
  • Specialty Clinics
  • Other End Uses
  • 6.6. Global Coronary Stents Market, Sub-Segmentation Of Dual Therapy Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sirolimus-Eluting Dual Therapy Stents
  • Paclitaxel-Eluting Dual Therapy Stents
  • Everolimus-Eluting Dual Therapy Stents
  • 6.7. Global Coronary Stents Market, Sub-Segmentation Of Radioactive Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Beta Radiation Stents
  • Gamma Radiation Stents
  • Other Radiation Stents
  • 6.8. Global Coronary Stents Market, Sub-Segmentation Of Thrombectomy Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Manual Thrombectomy Stents
  • Mechanical Thrombectomy Stents
  • Hydrodynamic Thrombectomy Stents
  • 6.9. Global Coronary Stents Market, Sub-Segmentation Of Covered Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PTFE-Covered Stents
  • ePTFE-Covered Stents
  • Polyurethane-Covered Stents
  • Other Covered Stents
  • 6.10. Global Coronary Stents Market, Sub-Segmentation Of Bioresorbable Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymer-Based Bioresorbable Stents
  • Metal-Based Bioresorbable Stents
  • Ceramic-Based Bioresorbable Stents
  • 6.11. Global Coronary Stents Market, Sub-Segmentation Of Biodegradable Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymeric Biodegradable Stents
  • Magnesium-Based Biodegradable Stents
  • Other Biodegradable Stents
  • 6.12. Global Coronary Stents Market, Sub-Segmentation Of Hybrid Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hybrid Drug-Eluting Stents
  • Hybrid Biodegradable Or Metal Stents
  • Other Hybrid Stents
  • 6.13. Global Coronary Stents Market, Sub-Segmentation Of Drug-Eluting Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sirolimus-Eluting Stents
  • Paclitaxel-Eluting Stents
  • Everolimus-Eluting Stents
  • Zotarolimus-Eluting Stents
  • Other Drug-Eluting Stents
  • 6.14. Global Coronary Stents Market, Sub-Segmentation Of Bare Metal Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stainless Steel Bare Metal Stents
  • Cobalt Chromium Bare Metal Stents
  • Other Bare Metal Stents

7. Coronary Stents Market Regional And Country Analysis

  • 7.1. Global Coronary Stents Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Coronary Stents Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Coronary Stents Market

  • 8.1. Asia-Pacific Coronary Stents Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Coronary Stents Market

  • 9.1. China Coronary Stents Market Overview
  • 9.2. China Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Coronary Stents Market

  • 10.1. India Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Coronary Stents Market

  • 11.1. Japan Coronary Stents Market Overview
  • 11.2. Japan Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Coronary Stents Market

  • 12.1. Australia Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Coronary Stents Market

  • 13.1. Indonesia Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Coronary Stents Market

  • 14.1. South Korea Coronary Stents Market Overview
  • 14.2. South Korea Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Coronary Stents Market

  • 15.1. Western Europe Coronary Stents Market Overview
  • 15.2. Western Europe Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Coronary Stents Market

  • 16.1. UK Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Coronary Stents Market

  • 17.1. Germany Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Coronary Stents Market

  • 18.1. France Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Coronary Stents Market

  • 19.1. Italy Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Coronary Stents Market

  • 20.1. Spain Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Coronary Stents Market

  • 21.1. Eastern Europe Coronary Stents Market Overview
  • 21.2. Eastern Europe Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Coronary Stents Market

  • 22.1. Russia Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Coronary Stents Market

  • 23.1. North America Coronary Stents Market Overview
  • 23.2. North America Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Coronary Stents Market

  • 24.1. USA Coronary Stents Market Overview
  • 24.2. USA Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Coronary Stents Market

  • 25.1. Canada Coronary Stents Market Overview
  • 25.2. Canada Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Coronary Stents Market

  • 26.1. South America Coronary Stents Market Overview
  • 26.2. South America Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Coronary Stents Market

  • 27.1. Brazil Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Coronary Stents Market

  • 28.1. Middle East Coronary Stents Market Overview
  • 28.2. Middle East Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Coronary Stents Market

  • 29.1. Africa Coronary Stents Market Overview
  • 29.2. Africa Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Coronary Stents Market Competitive Landscape And Company Profiles

  • 30.1. Coronary Stents Market Competitive Landscape
  • 30.2. Coronary Stents Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Biosensors International Group Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis

31. Coronary Stents Market Other Major And Innovative Companies

  • 31.1. Terumo Corporation
  • 31.2. W. L. Gore & Associates Inc.
  • 31.3. Cook Medical Inc.
  • 31.4. BIOTRONIK SE & Co. KG
  • 31.5. Lepu Medical Technology (Beijing) Co. Ltd.
  • 31.6. Meril Life Sciences Pvt. Ltd.
  • 31.7. MicroPort Scientific Corporation
  • 31.8. OrbusNeich
  • 31.9. Asahi Intecc Co. Ltd.
  • 31.10. Sahajanand Medical Technologies Limited
  • 31.11. Translumina GmbH
  • 31.12. Stentys S.A.
  • 31.13. Sorin Group
  • 31.14. InspireMD Inc.
  • 31.15. C. R. Bard Inc.

32. Global Coronary Stents Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Coronary Stents Market

34. Recent Developments In The Coronary Stents Market

35. Coronary Stents Market High Potential Countries, Segments and Strategies

  • 35.1 Coronary Stents Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Coronary Stents Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Coronary Stents Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer